Nice, France

Charlène Iltis

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique-Cnrs, Inserm (Institut National De La Santé Et De La Recherche Médicale), Université Cote D'azur. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charlène Iltis. Retrieved from https://idiyas.com/inventor/charlene-iltis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Charlène Iltis

Introduction

Charlène Iltis is a notable inventor based in Nice, France. She has made significant contributions to the field of medical research, particularly in the area of cell senescence. Her work has implications for treating diseases related to aging and cellular deterioration.

Latest Patents

Charlène Iltis holds a patent titled "Methods and Compositions for Treating Cell Senescence Accumulation Related Disease." This patent reflects her innovative approach to addressing health issues associated with aging cells.

Career Highlights

Throughout her career, Iltis has worked with prestigious research institutions. She has been associated with Inserm (Institut National de la Santé et de la Recherche Médicale) and the Centre National de la Recherche Scientifique (CNRS). Her work in these organizations has allowed her to contribute to groundbreaking research in her field.

Collaborations

Charlène Iltis has collaborated with esteemed colleagues, including Julien Cherfils and Eric Gilson. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Charlène Iltis is a pioneering inventor whose work in treating cell senescence is paving the way for advancements in medical science. Her contributions are vital in the ongoing quest to improve health outcomes related to aging.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…